CDH2 and neoplasm: Figure a–b depictsa prominent decrease in tumor volume in treated groups compared tocontrol and Quercetin­(25 mg/kg) groups. Immunofluorescence imagesin Figure c–ddemonstrated reduced NOX4, VEGF, and Ki-67 expression, accompanied by alterations in EMT markers (N-Cadherin,E-Cadherin, Vimentin), indicating a multipronged antitumor response.